<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03738930</url>
  </required_header>
  <id_info>
    <org_study_id>AI-mHealth-pilot</org_study_id>
    <nct_id>NCT03738930</nct_id>
  </id_info>
  <brief_title>Effectiveness of Artificial Intelligent Based mHealth System to Reduce ACS Patients Bleeding Events After PCI</brief_title>
  <official_title>Effectiveness of Artificial Intelligent Based mHealth System(Chronic Disease Management System) to Reduce ACS Patients Bleeding Events After PCI: Parallel Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study was designed to observe the effectiveness of artificial intelligent based
      mHealth system(Chronic disease management system) to reduce bleeding events in ACS patients
      undergoing PCI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 10, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of major bleeding during each visit between normal group and smartphone based group</measure>
    <time_frame>3 months</time_frame>
    <description>Bleeding definition：According to the bleeding Academic Research Congress (BARC) standard</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">420</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Percutaneous Coronary Intervention</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>normal follow-up group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>normal follow-up in ACS patients after PCI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AI based mHealth system follow-up group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AI based mHealth system follow-up in ACS patients after PCI. ACS patients in this group will receive message to take more notice to bleeding events.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>AI based mHealth system</intervention_name>
    <description>AI based mHealth system is used to deliver self-management contral message and health education message to make patients take notice of bleeding events after PCI.</description>
    <arm_group_label>AI based mHealth system follow-up group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        age≥18 years, male or female; confirmed acute coronary syndrome patients; undergo
        percutaneous coronary intervention (PCI) treatment; good command of smart phones agree to
        participate in this clinical study and sign a written consent form.

        Exclusion Criteria:

        ACS admission deemed secondary to other cause such as traffic accidents, trauma, severe
        upper gastrointestinal bleeding, surgery, or procedure; patients who are not intend to
        attend 1 year of follow-up study or investigators find that patients are not able to comply
        with the study's requirements; pregnant women or lactating women; investigators consider
        patients who were not suitable for participation with other reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yundai Chen, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>The General Hospital of PLA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dandan Li, Master</last_name>
    <phone>+86 15711017209</phone>
    <email>cardio_lidandan@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yundai Chen, Master</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The General Hospital of PLA</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dandan Li, Master</last_name>
      <phone>+86 15711017209</phone>
      <email>cardio_lidandan@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2018</study_first_posted>
  <last_update_submitted>November 8, 2018</last_update_submitted>
  <last_update_submitted_qc>November 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Yun Dai Chen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Acute Coronary Syndrome</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

